X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3384) 3384
Publication (436) 436
Book Chapter (45) 45
Book Review (13) 13
Dissertation (9) 9
Conference Proceeding (5) 5
Book / eBook (2) 2
Data Set (2) 2
Newspaper Article (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1958) 1958
index medicus (1401) 1401
cd38 (1383) 1383
male (953) 953
female (924) 924
cd38 expression (913) 913
hematology (881) 881
cd38 antigen (806) 806
middle aged (736) 736
adult (679) 679
oncology (667) 667
flow cytometry (631) 631
animals (589) 589
immunology (582) 582
aged (577) 577
prognosis (563) 563
leukemia, lymphocytic, chronic, b-cell - genetics (436) 436
adp-ribosyl cyclase (417) 417
chronic lymphocytic leukemia (400) 400
expression (398) 398
adp-ribosyl cyclase 1 (381) 381
biochemistry & molecular biology (373) 373
cyclic adp-ribose (372) 372
survival (367) 367
lymphocytes (363) 363
mice (351) 351
activation (349) 349
disease progression (345) 345
membrane glycoproteins (340) 340
aged, 80 and over (333) 333
cell biology (323) 323
apoptosis (307) 307
leukemia, lymphocytic, chronic, b-cell - pathology (304) 304
cancer (303) 303
adp-ribosyl cyclase 1 - metabolism (283) 283
cll (281) 281
lymphocytes t (280) 280
cells (277) 277
analysis (264) 264
leukemia (256) 256
medicine (245) 245
mutation (243) 243
gene expression (238) 238
zap-70 expression (238) 238
genomic aberrations (235) 235
multiple myeloma (231) 231
patients (229) 229
antigens, cd (227) 227
leukemia, lymphocytic, chronic, b-cell - diagnosis (226) 226
disease (224) 224
signal transduction (217) 217
research (216) 216
immunophenotyping (215) 215
research article (209) 209
hiv infections - immunology (205) 205
b-cells (201) 201
hemic and lymphatic diseases (201) 201
multidisciplinary sciences (201) 201
t cells (201) 201
hiv (200) 200
leukemia, lymphocytic, chronic, b-cell - immunology (198) 198
infectious diseases (197) 197
cd4 antigen (196) 196
leukemia, lymphocytic, chronic, b-cell - metabolism (195) 195
variable-region mutations (194) 194
nad (191) 191
pathology (191) 191
cells, cultured (188) 188
chronic lymphocytic-leukemia (187) 187
cell activation (185) 185
science (185) 185
zap-70 (184) 184
adp-ribosyl cyclase 1 - genetics (183) 183
differentiation (183) 183
lymphocytes b (178) 178
immunoglobulin heavy chains - genetics (176) 176
cd8 antigen (173) 173
health aspects (172) 172
medicine, research & experimental (172) 172
proteins (168) 168
cytokines (167) 167
leukemia, lymphocytic, chronic, b-cell - mortality (167) 167
gene mutation status (162) 162
therapy (162) 162
article (161) 161
diagnosis (161) 161
immunoglobulin variable region - genetics (161) 161
antigens (159) 159
stem cells (158) 158
histocompatibility antigen hla (157) 157
inflammation (155) 155
phenotype (154) 154
bone marrow (153) 153
genetic aspects (152) 152
care and treatment (150) 150
t-cells (149) 149
human immunodeficiency virus--hiv (147) 147
immune activation (147) 147
lymphocyte activation (144) 144
calcium - metabolism (142) 142
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3343) 3343
French (13) 13
Japanese (13) 13
Polish (12) 12
Russian (10) 10
Chinese (8) 8
Spanish (7) 7
German (5) 5
Czech (3) 3
Turkish (3) 3
Hungarian (2) 2
Korean (2) 2
Italian (1) 1
Persian (1) 1
Portuguese (1) 1
Romanian (1) 1
Serbian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Retrovirology, ISSN 1742-4690, 04/2015, Volume 12, Issue 1, p. 33
Journal Article
Cancer, ISSN 0008-543X, 07/2019, Volume 125, Issue 14, pp. 2364 - 2382
The development of effective monoclonal antibodies for the treatment of myeloma has been a long journey of clinical and drug development. Identification of the... 
infusion reactions | myeloma | daratumumab | myeloma management | CD38 monoclonal antibody | CELLS | DEXAMETHASONE | COMPLEMENT | MONOTHERAPY | MECHANISMS | BORTEZOMIB | POMALIDOMIDE | ONCOLOGY | LENALIDOMIDE | CD38 EXPRESSION | INTERFERENCE | Antigens | Refractory materials | Target recognition | CD38 antigen | Multiple myeloma | Clinical trials | Monoclonal antibodies | Drug development | Patients
Journal Article
IMMUNOLOGY LETTERS, ISSN 0165-2478, 07/2018, Volume 199, pp. 16 - 22
The fist in class CD38-targeting antibody, daratumumab, is currently approved as single agent and in combination with standards of care for the treatment of... 
MULTIPLE-MYELOMA | Adenosine | EFFICACY | PD-1 BLOCKADE | Multiple myeloma | IMMUNOLOGY | ANTITUMOR-ACTIVITY | CELL-DEATH | TARGETING CD38 | MICROENVIRONMENT | Daratumumab | Monoclonal antibodies | CD38 | CD38 EXPRESSION | NIVOLUMAB
Journal Article
Frontiers in Immunology, ISSN 1664-3224, 06/2018, Volume 9, p. 1228
This mini-review will summarize the present state of development of the CD38 antibody daratumumab for the treatment of multiple myeloma. 
Adenosine | Immunomodulation | Daratumumab | CD38 | Complement | Myeloma | Neonatal Fc-receptors | Trogocytosis | trogocytosis | immunomodulation | DEXAMETHASONE | MONOTHERAPY | BORTEZOMIB | IMMUNOLOGY | PLASMA-CELLS | adenosine | TARGETING CD38 | myeloma | THERAPY | CLINICAL-EFFICACY | LENALIDOMIDE | CD38 EXPRESSION | INTERFERENCE | daratumumab | complement | neonatal Fc-receptors
Journal Article
Bioorganic and Medicinal Chemistry, ISSN 0968-0896, 11/2010, Volume 18, Issue 22, pp. 7900 - 7910
Schistosomiasis is a major tropical parasitic disease. For its treatment, praziquantel remains the only effective drug available and the dependence on this... 
CD38 antigen
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 2019, Volume 294, Issue 11, pp. 4247 - 4258
Journal Article
IMMUNOLOGY LETTERS, ISSN 0165-2478, 01/2019, Volume 205, pp. 71 - 77
The fist in class CD38-targeting antibody, daratumumab, is currently approved as single agent and in combination with standards of care for the treatment of... 
MULTIPLE-MYELOMA | Adenosine | PD-1 BLOCKADE | Multiple myeloma | IMMUNOLOGY | ANTITUMOR-ACTIVITY | IMMUNE CHECKPOINT | CELL-DEATH | TARGETING CD38 | MICROENVIRONMENT | Daratumumab | Monoclonal antibodies | CD38 | CD38 EXPRESSION | NIVOLUMAB | Medical research | Immune response | Biological products | Analysis | Immunotherapy | Medicine, Experimental | B cells | T cells
Journal Article
Transfusion Medicine, ISSN 0958-7578, 06/2019, Volume 29, Issue 3, pp. 193 - 196
SUMMARY Objectives To report our 2 years of experience navigating the interference of anti‐CD38 monoclonal antibodies (MAs) in 33 patients and describe... 
anti‐CD38 therapies | multiple myeloma | alloantibody identification | transfusion | interference | TARGETING CD38 | DARATUMUMAB INTERFERENCE | ANTIBODY | anti-CD38 therapies | HEMATOLOGY | Care and treatment | Digital television | Multiple myeloma | Papain | Blood banks | Blood transfusion | Methods
Journal Article
Immunology Letters, ISSN 0165-2478, 01/2019, Volume 205, pp. 71 - 77
The fist in class CD38-targeting antibody, daratumumab, is currently approved as single agent and in combination with standards of care for the treatment of... 
Monoclonal antibodies | CD38 | Adenosine | Daratumumab | Multiple myeloma
Journal Article
01/2012
This study was designed to assess the effect of GB virus (GBV)-C on the immune response to human immunodeficiency virus (HIV) in chronically HIV-infected and... 
Tγδ | HIV | immune activation | GBV-C/HGV | CD38 | cytokines
Web Resource
Biochemical Pharmacology, ISSN 0006-2952, 11/2019, Volume 169, p. 113620
Aryl hydrocarbon receptor (AHR), identified in studies of dioxin toxicity, has been characterized as ligand-activated transcription factor involved in diverse... 
NASH | AHR, CD38, NAD metabolism | Hepatic steatosis
Journal Article
Cell Reports, ISSN 2211-1247, 01/2017, Volume 18, Issue 5, pp. 1241 - 1255
Journal Article